Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acquired immunodeficiency syndrome
Africa
alopecia
antiviral agents
areflexia
ataxic gait
CAT scan, chest
CD4 counts
cerebellar lesion
Clinical Pathologic Conference(C.P.C.)
coinfection
dizziness
dysmetria
finger nose finger test
gait disorder
Guillain Barre syndrome
Guillain Barre syndrome, differential diagnosis of
headache
headache, progressive
herpes simplex virus
herpes virus
herpes virus infection
herpes, genital
human immunodeficiency virus type 1, false positive
human immunodeficiency virus type 2
hyponatremia
imbalance
immunosuppression
inappropriate antidiuretic(A.D.H.)hormone
lethargy
lymphopenia
meningeal enhancement
metamyelocytes
MRI, abnormal
MRI, contrast enhanced
MRI, ring sign
nerve conduction studies
nystagmus
opportunistic infection
opportunistic infection, CNS
pain, abdominal
paresthesias
pleocytosis of cerebrospinal fluid
progressive neurologic disorder
sensory loss, band distribution
suspended sensory loss
thrush
toxoplasmosis, CNS
treatment of neurologic disorder
viral infection
walking, difficulty with
weakness
weakness, generalized
weakness, progressive
weight loss
Showing articles 350 to 400 of 1173 << Previous Next >>

Cerebral Microbleed Preceding Symptomatic Intracerebral Hemorrhage in a Stroke-Free Person
Neurol 72:763-765, Vernooij,M.W.,et al, 2009

Moyamoya Disease and Moyamoya Syndrome
NEJM 360:1226-1237, Scott,R.M. &Smith,E.R., 2009

Stroke in Women: An Evolving Topic
Stroke 40:1027-1028, Kurth,T. &Bousser,M.-G., 2009

Effect of Age on Stroke Prevention Therapy in Patients with Atrial Fibrillation: The Atrial Fibrillation Investigators
Stroke 40:1410-1416, van Walraven,C.,et al, 2009

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
NEJM 360:2066-2078,2127, The ACTIVE Investigators, 2009

Does the Combination of Warfarin and Aspirin Have a Place in Secondary Stroke Prevention? No
Stroke 40:1944-1945,1946, Fisher,M., 2009

Does the Combination of Warfarin and Aspirin Have a Place in Secondary Stroke Prevention? Yes
Stroke 40:1942-1943,1946, Furlan,A.J., 2009

Prior Antiplatelet Use Dose Not Affect Hemorrhage Growth or Outcome After ICH
Neurol 72:1397-1402,1376, Sansing,L.H.,et al, 2009

The Neurologic Manifestations of Systemic Lupus Erythematosus
The Neurologist 15:115-121, Greenberg,B.M., 2009

Intracerebral Haemorrhage
Lancet 373:1632-1644, Qureshi,A.I.,et al, 2009

Treatment of Atherosclerotic Intracranial Arterial Stenosis
Stroke 40:2257-2261, Turan,T.N.,et al, 2009

Spontaneous Primary Intraventricular Hemorrhage in Adults: Clinical Data, Etiology and Outcome
Turkish Neurosurgery 19:338-344, Giray, S.,et al, 2009

Lateral Sinus Thrombosis: Complication of Minor Head Injury
Int J Pediatr Otorhinolaryngol 73:629-635, Nehme, J.,et al, 2009

May-Thurner Syndrome in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Stroke 40:1502-1504, Kiernan, T.J.,et al, 2009

Cerebral Microbleeds Are a Risk Factor for Warfarin-Related Intracerebral Hemorrhage
Neurol 72:171-176, Lee,S.-H.,et al, 2009

Potentially Preventable Strokes in High-Risk Patients with Atrial Fibrillation Who Are Not Adequately Anticoagulated
Stroke 40:235-240,5, Gladstone,D.J.,et al, 2009

Aspirin vs Anticoagulation in Carotid Artery Dissection: A Study of 298 Patients
Neurol 72:1810-1815,1800, Georgiadis,D.,et al, 2009

Clinicopath Conf, Neuro-Behcets Disease
NEJM 360:2341-2351, Case 17-2009, 2009

Hemorrhage in Posterior Reversible Encephalopathy Syndrome: Imaging and Clinical Features
AJNR 30:1371-1379, Hefzy,H.M.,et al, 2009

Recurrent Cerebral Ischemia in Medically Treated Patent Foramen Ovale: A Meta-Analysis
Neurol 73:89-97,84, Almekhlafi,M.A.,et al, 2009

Use of Antithrombotic Drugs and the Presence of Cerebral Microbleeds: The Rotterdam Scan Study
Arch Neurol 66:714-720,691, Vernooij,M.W.,et al, 2009

Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients with Atrial Fibrillation: A Randomised Non-Inferiority Trial
Lancet 374:534-542,504, Holmes,D.R.,et al, 2009

Antithrombotic Management of Patients with Prosthetic Heart Valves: Current Evidence and Future Trends
Lancet 374:565-576, Sun,J.C.J.,et al, 2009

Who Is Ineligible for Warfarin in Atrial Fibrillation?
Lancet 374:510-511, Verheugt,F.W.A., 2009

Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009

Lamotrigine Kinetics Within the Menstrual Cycle, After Menopause, and with Oral Contraceptives
Neurol 73:1388-1393, Wegner,I.,et al, 2009

Point-of-Care International Normalized Ratio Testing Accelerates Thrombolysis in Patients With Acute Ischemic Stroke Using Oral Anticoagulants
Stroke 40:3547-3551, Rizos,T.,et al, 2009

Medial Medullary Infarction: Clinical, Imaging, and Outcome Study in 86 Consecutive Patients
Stroke 40:3221-3225, Kim,J. &Han,Y., 2009

Dabigatran Versus Warfarin in Patients with Atrial Fibrillation
NEJM 361:1139-1151, 1200, Connolly,S.,et al, 2009

Outcome of Symptomatic Intracranial Atherosclerotic Disease
Stroke 40:2983-2987, Samaniego,E.,et al, 2009

Intracranial Atherosclerotic Disease: An Update
Ann Neurol 66:730-738, Qureshi,A.,et al, 2009

N-Methyl-D-Aspartate Receptor Antibodies in Pediatric Dyskinetic Encephalitis Lethargica
Ann Neurol 66:704-709, Dale,R.,et al, 2009

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Admission International Normalized Ratio and Acute Infarct Volume in Ischemic Stroke
Ann Neurol 64:499-506, Ay,H.,et al, 2008

Managing the Anticoagulated Patient with Atrial Fibrillation at High Risk of Stroke Who Needs Coronary Intervention
BMJ 337:1110-1111, Lip,G.Y.H., 2008

Barriers to the Use of Anticoagulation for Nonvalvular Atrial Fibrillation: A Representative Survey of Australian Family Physicians
Stroke 39:227-230,7, Gattellari,M.,et al, 2008

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stoke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)
Stroke 39:89-99, Adams,H.P.,Jr.,et al, 2008

Management of Carotid Stenosis
NEJM 3585:1617-1621, Sila,C.A., 2008

Aspirin Plus Dipyridamole Versus Aspirin for Prevention of Vascular Events After Stroke or TIA: A Meta-Analysis
Stroke 39:1358-1363, Verro,P.,et al, 2008

Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks
Stroke 39:1399-1400, Aguilar,M.I. &Hart,R., 2008

Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk: The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)
Stroke 39:1482-1486,1406, Healey,J.S.,et al, 2008

Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation
Stroke 39:1901-1910, Stroke Risk in Atrial Fibrillation Working Group, 2008

Stroke
Lancet 371:1612-1623, Donnan,G.A.,et al, 2008

Safety of Antiplatelet Therapy Prior to Intravenous Thrombolysis in Acute Ischemic Stroke
Arch Neurol 65:607-611,575, Uyttenboogaart,M.,et al, 2008

Progress in Secondary Stroke Prevention
Ann Neurol 63:418-427, Romano,J.G. &Sacco,R.L., 2008

Treatment of Childhood Arterial Ischemic Stroke
Ann Neurol 63:679-696, Bernard,T.J.,et al, 2008

Antiplatelet Therapy in Aneurysmal Subarachnoid Hemorrhage
Stroke 39:2186-2187, Dorhout Mees,S.M.,et al, 2008

Sinus Thrombosis Should Be Treated With Anticoagulation
Arch Neurol 65:984-985,987, Stam,J., 2008

Anticoagulation in Cerebral Venous Sinus Thrombosis: Are We Treating Ourselves?
Arch Neurol 65:985-987,987, Wasay,M. &Kamal,A.K., 2008

Initial Management of Epilepsy
NEJM 359:166-176, French,J.A. &Pedley,T.A., 2008



Showing articles 350 to 400 of 1173 << Previous Next >>